UPDATE: Benchmark Downgrades Tilray (TLRY) to Hold on Valuation

February 18, 2021 6:12 AM EST
Get Alerts TLRY Hot Sheet
Price: $15.89 -8.89%

Rating Summary:
    0 Buy, 17 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 7 | Down: 16 | New: 68
Trade Now! 
Join SI Premium – FREE
(Updated - February 18, 2021 8:38 AM EST)

Benchmark analyst Mike Hickey downgraded Tilray (NASDAQ: TLRY) from Buy to Hold with a $32 price target.

The analyst commented, "TLRY delivered better than expected F4Q20 performance and delivered positive Adjusted EBITDA, as guided. We are downgrading to Hold from Buy based on valuation as the share price has exceeded our prior $12 PT by 163%. The proposed merger with Aphria is expected to close in F2Q21 and should create the world largest cannabis Company based on pro-forma revenue and with a target of C$100M in anticipated pre-tax synergies that should enable a step up in profit."

For an analyst ratings summary and ratings history on Tilray click here. For more ratings news on Tilray click here.

Shares of Tilray closed at $34.35 yesterday.


You May Also Be Interested In





Related Categories

Analyst Comments, Downgrades

Related Entities

Definitive Agreement